These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 8070894

  • 1. FGF-2 in the MPTP model of Parkinson's disease: effects on astroglial cells.
    Otto D, Unsicker K.
    Glia; 1994 May; 11(1):47-56. PubMed ID: 8070894
    [Abstract] [Full Text] [Related]

  • 2. Early effects of FGF-2 on glial cells in the MPTP-lesioned striatum.
    Wirth SB, Rufer M, Unsicker K.
    Exp Neurol; 1996 Feb; 137(2):191-200. PubMed ID: 8635534
    [Abstract] [Full Text] [Related]

  • 3. FGF-2-mediated protection of cultured mesencephalic dopaminergic neurons against MPTP and MPP+: specificity and impact of culture conditions, non-dopaminergic neurons, and astroglial cells.
    Otto D, Unsicker K.
    J Neurosci Res; 1993 Mar 01; 34(4):382-93. PubMed ID: 8097265
    [Abstract] [Full Text] [Related]

  • 4. Identification of brain-derived neurotrophic factor in nestin-expressing astroglial cells in the neostriatum of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice.
    Chen LW, Hu HJ, Liu HL, Yung KK, Chan YS.
    Neuroscience; 2004 Mar 01; 126(4):941-53. PubMed ID: 15207328
    [Abstract] [Full Text] [Related]

  • 5. Neuronal and astroglial responses to the serotonin and norepinephrine neurotoxin: 1-methyl-4-(2'-aminophenyl)-1,2,3,6-tetrahydropyridine.
    Luellen BA, Miller DB, Chisnell AC, Murphy DL, O'Callaghan JP, Andrews AM.
    J Pharmacol Exp Ther; 2003 Dec 01; 307(3):923-31. PubMed ID: 14561848
    [Abstract] [Full Text] [Related]

  • 6. Expression of S-100 protein is related to neuronal damage in MPTP-treated mice.
    Muramatsu Y, Kurosaki R, Watanabe H, Michimata M, Matsubara M, Imai Y, Araki T.
    Glia; 2003 May 01; 42(3):307-13. PubMed ID: 12673835
    [Abstract] [Full Text] [Related]

  • 7. Localization of nerve growth factor, neurotrophin-3, and glial cell line-derived neurotrophic factor in nestin-expressing reactive astrocytes in the caudate-putamen of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated C57/Bl mice.
    Chen LW, Zhang JP, Kwok-Yan Shum D, Chan YS.
    J Comp Neurol; 2006 Aug 20; 497(6):898-909. PubMed ID: 16802332
    [Abstract] [Full Text] [Related]

  • 8. Regulation of connexin-43, GFAP, and FGF-2 is not accompanied by changes in astroglial coupling in MPTP-lesioned, FGF-2-treated parkinsonian mice.
    Rufer M, Wirth SB, Hofer A, Dermietzel R, Pastor A, Kettenmann H, Unsicker K.
    J Neurosci Res; 1996 Dec 01; 46(5):606-17. PubMed ID: 8951672
    [Abstract] [Full Text] [Related]

  • 9. The MAP kinase cascade is activated prior to the induction of gliosis in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) model of dopaminergic neurotoxicity.
    O'Callaghan JP, Martin PM, Mass MJ.
    Ann N Y Acad Sci; 1998 May 30; 844():40-9. PubMed ID: 9668663
    [Abstract] [Full Text] [Related]

  • 10. Pyrethroid and organophosphate insecticide exposure in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease: an immunohistochemical analysis of tyrosine hydroxylase and glial fibrillary acidic protein in dorsolateral striatum.
    Dodd CA, Klein BG.
    Toxicol Ind Health; 2009 Feb 30; 25(1):25-39. PubMed ID: 19318502
    [Abstract] [Full Text] [Related]

  • 11. Astroglial plasticity and glutamate function in a chronic mouse model of Parkinson's disease.
    Dervan AG, Meshul CK, Beales M, McBean GJ, Moore C, Totterdell S, Snyder AK, Meredith GE.
    Exp Neurol; 2004 Nov 30; 190(1):145-56. PubMed ID: 15473988
    [Abstract] [Full Text] [Related]

  • 12. [A mouse model of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine induced parkinsonism: effect of norepinephrine terminal destruction].
    Nishi K, Kondo T, Narabayashi H.
    No To Shinkei; 1987 Jul 30; 39(7):663-72. PubMed ID: 3314916
    [Abstract] [Full Text] [Related]

  • 13. FGF-2 deficiency does not alter vulnerability of the dopaminergic nigrostriatal system towards MPTP intoxication in mice.
    Zechel S, Jarosik J, Kiprianova I, Schober A, Unsicker K, von Bohlen und Halbach O.
    Eur J Neurosci; 2006 Mar 30; 23(6):1671-5. PubMed ID: 16553632
    [Abstract] [Full Text] [Related]

  • 14. Astrocyte delivery of glial cell line-derived neurotrophic factor in a mouse model of Parkinson's disease.
    Cunningham LA, Su C.
    Exp Neurol; 2002 Apr 30; 174(2):230-42. PubMed ID: 11922664
    [Abstract] [Full Text] [Related]

  • 15. Neurotrophic and neurorescue effects of Echinacoside in the subacute MPTP mouse model of Parkinson's disease.
    Zhao Q, Gao J, Li W, Cai D.
    Brain Res; 2010 Jul 30; 1346():224-36. PubMed ID: 20478277
    [Abstract] [Full Text] [Related]

  • 16. Adrenalectomy counteracts the local modulation of astroglial fibroblast growth factor system without interfering with the pattern of 6-OHDA-induced dopamine degeneration in regions of the ventral midbrain.
    Chadi G, Silva C, Maximino JR, Fuxe K, da Silva GO.
    Brain Res; 2008 Jan 23; 1190():23-38. PubMed ID: 18086466
    [Abstract] [Full Text] [Related]

  • 17. Arundic acid, an astrocyte-modulating agent, protects dopaminergic neurons against MPTP neurotoxicity in mice.
    Kato H, Kurosaki R, Oki C, Araki T.
    Brain Res; 2004 Dec 24; 1030(1):66-73. PubMed ID: 15567338
    [Abstract] [Full Text] [Related]

  • 18. Role of nuclear transcription factor kappa B (NF-kappaB) for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahyropyridine)-induced apoptosis in nigral neurons of mice.
    Aoki E, Yano R, Yokoyama H, Kato H, Araki T.
    Exp Mol Pathol; 2009 Feb 24; 86(1):57-64. PubMed ID: 19027004
    [Abstract] [Full Text] [Related]

  • 19. Estrogen down-regulates glial activation in male mice following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine intoxication.
    Tripanichkul W, Sripanichkulchai K, Finkelstein DI.
    Brain Res; 2006 Apr 21; 1084(1):28-37. PubMed ID: 16564034
    [Abstract] [Full Text] [Related]

  • 20. Protective actions of human recombinant basic fibroblast growth factor on MPTP-lesioned nigrostriatal dopamine neurons after intraventricular infusion.
    Chadi G, Møller A, Rosén L, Janson AM, Agnati LA, Goldstein M, Ogren SO, Pettersson RF, Fuxe K.
    Exp Brain Res; 1993 Apr 21; 97(1):145-58. PubMed ID: 7907549
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.